Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?
- Ampudia-Blasco, F.J.
- Romera, I.
- Ariño, B.
- Gomis, R.
Revista:
International Journal of General Medicine
ISSN: 1178-7074
Ano de publicación: 2017
Volume: 10
Páxinas: 23-26
Tipo: Artigo